vaccin
greatli
reduc
burden
infecti
diseas
prevent
around
million
annual
death
worldwid
howev
exist
vaccin
prevent
approxim
lifethreaten
infect
thu
new
vaccin
well
novel
approach
effect
induc
protect
immun
urgent
need
pathogen
use
epitheli
barrier
respiratori
mycobacterium
tuberculosi
adenoviru
coronaviru
gastrointestin
salmonella
helicobact
pylori
escherichia
coli
urogenit
tract
chlamydia
human
papillomaviru
human
immunodefici
viru
port
entri
accordingli
element
mucos
immun
includ
antigenspecif
secretori
iga
cell
cytokin
antimicrobi
peptid
promot
protect
infect
howev
tradit
inject
vaccin
gener
poor
induc
mucos
immun
therefor
less
effect
mucos
infect
mucos
vaccin
henc
import
investig
induct
mainten
mucos
immun
order
gener
effect
vaccin
multipl
pathogen
known
pattern
recognit
receptor
prr
play
essenti
role
format
immun
defens
mucos
surfac
benefici
effect
prr
signal
mucos
protect
immun
establish
abil
prr
agonistbas
adjuv
promot
local
mucos
immun
reaction
parenter
vaccin
extens
investig
thu
subcutan
prime
follow
airway
booster
immun
clinic
approv
adjuv
load
ctype
lectin
clr
agonist
tdb
recent
demonstr
induc
strong
immun
reaction
airway
mucosa
includ
enhanc
format
cell
abund
iga
secret
howev
mucos
adjuv
base
clr
agonist
remain
larg
uncharacter
henc
investig
abil
tdb
curdlan
furfurman
stimul
mincl
respect
elicit
mucos
system
immun
reaction
via
sever
transcript
factor
nfat
cellular
pathway
cytokin
secret
matur
dendrit
cell
headtohead
comparison
use
report
cell
line
show
agonist
activ
transcript
factor
vari
extent
vitro
studi
show
tdb
curdlan
elicit
product
mix
cytokin
wherea
furfurman
predominantli
induc
product
cytokin
final
demonstr
first
time
subcutan
primeboost
immun
curdlan
furfurman
tdb
boost
iga
product
intestin
mucosa
parenter
immun
collect
result
highlight
agonist
potenti
adjuv
induc
local
mucos
immun
parenter
immun
cell
use
prepar
lentivir
stock
cell
transfect
vector
use
lipofectamineplu
reagent
invitrogen
usa
two
helper
plasmid
pvsvg
addgen
usa
cotransfect
along
experiment
plasmid
correspondingli
lentivir
plasmid
carri
transcript
factor
nfat
induc
luciferas
report
gene
obtain
system
bioscienc
usa
supernat
contain
infecti
viral
particl
harvest
h
posttransfect
pool
filter
rawblu
cell
deriv
raw
murin
macrophag
obtain
invivogen
use
parent
cell
line
cell
cultur
medium
contain
lentivirus
three
differ
report
lvnfatluc
use
transduct
target
cell
obtain
three
separ
report
line
rawnfatluc
correspondingli
next
day
puromycin
ad
cell
cultur
medium
select
transduc
cell
report
cell
rawnfatluc
cultur
dmem
medium
ge
healthcar
usa
supplement
fetal
bovin
serum
fb
thermo
fisher
scientif
usa
uml
penicillin
streptomycin
mm
glutamin
paneco
russia
use
protocol
describ
previou
work
name
experi
cell
seed
cellswel
plate
next
day
ctype
lectin
receptor
agonist
ad
well
final
concentr
eight
hour
later
detect
luciferas
activ
brightglo
luciferas
assay
buffer
contain
luciferin
substrat
promega
usa
ad
well
luminesc
measur
rel
unit
use
synergi
hybrid
reader
biotek
germani
femal
week
old
spf
mice
purchas
nurseri
pushchino
institut
bioorgan
chemistri
russia
mice
fed
complet
pellet
laboratori
chow
access
food
water
ad
libitum
mice
hous
cage
micecag
isocag
isol
system
tecniplast
itali
experiment
procedur
conform
guid
care
use
laboratori
anim
publish
nation
institut
health
nih
public
number
revis
approv
local
ethic
committe
nf
gamaleya
nation
research
center
epidemiolog
microbiolog
mice
euthan
overdos
prior
autopsi
bone
marrowderiv
dendrit
cell
bmdc
mice
differenti
prolifer
mous
bone
marrow
progenitor
induct
ngml
granulocyt
macrophag
colonystimul
factor
gmcsf
r
system
usa
day
describ
briefli
mice
euthan
overdos
femur
tibia
collect
phosphat
buffer
salin
pb
solut
sigmaaldrich
usa
muscl
remov
scalpel
epiphys
cut
scissor
bone
marrow
flush
ml
rpmi
medium
syring
needl
resuspend
bone
marrow
cell
collect
wash
twice
pb
bone
marrow
cell
cultur
petri
dish
contain
approxim
cellsml
ml
total
volum
cell
maintain
complet
rpmi
medium
heat
inactiv
fetal
bovin
serum
fb
thermo
fisher
scientif
usa
mm
mercaptoethanol
thermo
fisher
scientif
usa
essenti
nonessenti
amino
acid
paneco
russia
ngml
gmcsf
mm
glutamin
uml
penicillin
streptomycin
mm
sodium
pyruv
mm
hepe
ph
paneco
russia
hour
ml
fresh
media
ad
petri
dish
day
half
medium
dish
replac
ml
fresh
medium
day
percentag
cell
cultur
bmdc
splenocyt
seed
plate
cell
per
well
complet
rpmi
medium
cell
treat
clr
agonist
final
concentr
triplic
twentyfour
hour
treatment
plate
centrifug
min
cultur
supernat
collect
level
cytokin
chemokin
eotaxin
gcsf
gmcsf
kc
rant
well
measur
prepar
supernat
use
beadbas
assay
group
bioplex
pro
kit
accord
manufactur
instruct
biorad
usa
bmdc
seed
plate
cell
per
well
ml
rpmi
complet
medium
tdb
curdlan
furfurman
ad
cell
concentr
hour
cell
collect
wash
twice
pb
stain
stain
buffer
bd
bioscienc
usa
min
surfac
marker
fluoresc
label
antibodi
clone
antimhciip
clone
clone
clone
clone
bd
bioscienc
usa
cell
analyz
fac
aria
iii
instrument
bd
bioscienc
usa
obtain
vaccin
composit
ovalbumin
sigmaaldrich
usa
mix
individu
clr
agonist
tdb
curdlan
furfurman
invivogen
usa
steril
pb
interact
antigen
individu
clr
agonist
measur
surfac
plasmon
reson
imag
squalenebas
vaccin
formul
made
thorough
mix
ovalbumin
antigen
clr
agonist
squalen
sigmaaldrich
usa
tween
panreac
applichem
germani
volum
formul
adjust
pb
total
mixtur
sonic
sec
branson
usa
emuls
stabl
two
week
particl
size
nm
chang
stabil
control
zetas
nano
zs
malvern
uk
mice
immun
subcutan
rout
sc
volum
base
tail
two
immun
given
week
interv
spleen
intact
mice
harvest
dissoci
use
scissor
nylon
cell
strainer
falcon
usa
splenocyt
purifi
ficol
gml
paneco
russia
densiti
gradient
centrifug
min
wash
twice
pb
mononuclear
cell
count
normal
use
autom
cell
counter
biorad
usa
mice
euthan
day
second
immun
splenic
mononuclear
cell
isol
accord
abovement
method
analysi
antigenspecif
cell
prolifer
respons
cell
stain
carboxyfluorescein
succinimidyl
ester
cfse
tracer
kit
invitrogen
usa
describ
previous
seed
plate
cell
per
well
cell
restimul
whole
ovalbumin
antigen
cultur
complet
rpmi
medium
hour
later
cell
harvest
wash
pb
stain
use
bd
pharmingen
mous
tlymphocyt
subset
antibodi
cocktail
correspond
isotyp
control
min
stain
buffer
bd
bioscienc
usa
accord
manufactur
instruct
cell
analyz
fac
aria
iii
instrument
bd
bioscienc
usa
two
week
second
immun
mice
euthan
overdos
blood
sampl
taken
use
syring
heart
thoracotomi
collect
blood
sampl
incub
min
centrifug
min
supernat
serum
immedi
aliquot
store
bronchoalveolar
lavag
bal
specimen
obtain
use
gaug
lavag
tube
infus
ml
pb
lung
via
trachea
follow
aspir
fluid
syring
collect
intestin
lavag
il
sampl
small
intestin
remov
care
fill
ml
pb
contain
sigmafast
proteas
inhibitor
cocktail
sigma
usa
use
syring
min
incub
solut
transfer
ml
conic
tube
eppendorf
germani
tube
place
ice
sonic
minut
ultrason
water
bath
elma
schmidbauer
germani
sampl
centrifug
minut
rpm
obtain
bal
il
sampl
immedi
aliquot
store
analysi
total
ovalbuminspecif
igg
igg
isotyp
titer
blood
serum
iga
titer
intestin
alveolar
lavag
fluid
measur
sampl
collect
mice
day
second
immun
microtit
plate
costar
usa
coat
per
well
ovalbumin
solut
carbon
buffer
ph
overnight
next
day
plate
wash
three
time
pb
contain
tween
tpb
block
wv
nonfat
milk
tpb
minut
rpm
individu
mous
sera
lavag
fluid
five
mice
per
group
analyz
individu
serial
twofold
dilut
prepar
tpb
contain
wv
nonfat
milk
sampl
per
well
ad
coat
wash
block
elisa
plate
incub
plate
sampl
hour
plate
wash
four
time
tpb
horseradish
peroxidaselabel
secondari
antibodi
ad
well
secondari
hrpconjug
antibodi
goat
polyclon
antibodi
mous
total
igg
ge
healthcar
germani
goat
polyclon
antibodi
mous
goat
polyclon
antibodi
mous
iga
abcam
uk
dilut
tpb
contain
wv
nonfat
milk
plate
incub
hour
wash
five
time
tpb
detect
bound
antibodi
peroxidas
substrat
tmb
ad
well
plate
incub
rt
min
color
develop
reaction
stop
use
optic
densiti
od
well
measur
nm
use
spectrophotometr
plate
reader
multiscan
fc
thermo
fisher
scientif
usa
follow
method
measur
antigenspecif
antibodi
titer
serum
materi
method
molecular
weight
mw
tdb
curdlan
furfurman
determin
use
malditof
mass
spectromet
ultraflextrem
bruker
dalton
germani
posit
ion
detect
reflectron
mode
use
follow
voltag
kv
kv
lens
kv
reflectron
kv
kv
ion
detect
rang
mz
th
linear
mode
rang
th
follow
voltag
ion
sourc
kv
kv
lens
kv
interact
clr
agonist
ovalbumin
determin
surfac
plasmon
reson
spr
use
biacor
ge
healthcar
uppsala
sweden
equip
researchgrad
sensor
chip
ge
healthcar
temperatur
ovalbumin
immobil
amount
respons
unit
ru
mm
acet
buffer
ph
sensor
chip
use
amin
coupl
kit
suppli
manufactur
ge
healthcar
sweden
tdb
curdlan
furfurman
use
concentr
control
nonspecif
bind
agonist
antigen
use
cpg
oligonucleotid
invivogen
usa
concentr
prr
agonist
dissolv
steril
deioniz
water
contain
vv
dmso
analys
perform
mm
hbsep
run
buffer
hepe
buffer
salin
contain
mm
nacl
mm
edta
surfact
ph
flow
rate
calcul
perform
use
biaevalu
softwar
ge
healthcar
uppsala
sweden
referencesubtract
fit
repres
imag
spr
shown
figur
experi
perform
three
time
unless
otherwis
specifi
data
express
mean
sd
valu
experi
statist
signific
assess
use
twotail
unpair
ttest
threshold
set
p
stimul
sykcoupl
clr
previous
shown
activ
sever
proinflammatori
transcript
factor
includ
nfat
respons
microbi
infect
tissu
damag
howev
transcript
respons
trigger
differ
clr
directli
compar
thu
use
curdlan
furfurman
tdb
investig
nfat
express
exogen
luciferas
report
gene
three
sublin
deriv
raw
macrophag
express
endogen
mincl
maximum
luciferas
express
observ
cell
expos
tdb
express
increas
rel
untreat
cell
respect
figur
dose
curdlan
furfurman
result
increas
express
increas
express
hand
maximum
nfat
activ
achiev
tdb
curdlan
contrast
furfurman
activ
nfat
significantli
lower
degre
normal
express
individu
promot
total
express
also
highlight
differenti
transcript
respons
agonist
figur
collect
data
impli
stimul
clr
mincl
result
differ
transcript
profil
despit
engag
signal
cascad
base
observ
differ
activ
level
nfat
transcript
factor
hypothes
clr
agonist
may
also
affect
downstream
immun
reaction
differ
way
dendrit
cell
determin
magnitud
polar
adapt
immun
abundantli
express
clr
quantifi
matur
marker
bone
marrowderiv
dendrit
cell
expos
h
tdb
curdlan
furfurman
stimul
mincl
tdb
increas
express
respect
curdlan
also
enhanc
express
wherea
furfurman
induc
express
figur
addit
agonist
also
induc
variou
extent
secret
cytokin
chemokin
test
figur
b
particular
tdb
elicit
strongest
express
kc
rant
hand
increas
strongli
induc
presenc
curdlan
effect
stimul
furfurman
curdlan
furfurman
stimul
express
compar
extent
polar
adapt
immun
also
driven
cytokin
chemokin
secret
lymphocyt
among
differ
th
subset
identifi
base
signatur
cytokin
profil
evalu
cellular
immun
reaction
similar
vivo
inject
quantifi
cytokin
chemokin
h
stimul
splenic
mononuclear
cell
tdb
curdlan
furfurman
strikingli
secret
cytokin
chemokin
enhanc
rel
control
cell
figur
although
effect
secret
depend
agonist
exampl
maxim
induc
tbd
along
gcsf
similarli
curdlan
induc
effect
agonist
tdb
curdlan
also
induc
strongli
furfurman
surprisingli
furfurman
induc
robustli
tdb
curdlan
affect
cytokin
chemokin
taken
togeth
data
demonstr
clr
agonist
elicit
strong
proinflammatori
respons
variou
extent
tdb
curdlan
furfurman
matur
bone
marrowderiv
dendrit
cell
well
induc
cytokin
secret
cell
mononuclear
cell
agonist
may
induc
strong
adapt
immun
respons
vivo
use
adjuv
therefor
evalu
immun
respons
ovalbumin
prepar
without
agonist
note
immun
respons
complex
evalu
absenc
addit
carrier
exampl
alum
squalen
other
sinc
carrier
may
greatli
influenc
immun
respons
shift
polar
detect
strong
interact
ovalbumin
clr
agonist
molecul
k
valu
ovatdb
ovacurdlan
ovafurfurman
resp
measur
surfac
plasmon
reson
figur
cpg
oligonucleotid
use
neg
control
measur
nonspecif
bind
mean
diamet
surfac
charg
zpotenti
ovalbuminagonist
complex
also
evalu
tabl
k
valu
observ
increas
mean
diamet
antigen
clr
agonist
mixtur
compar
individu
compon
suggest
stabl
complex
form
mixtur
administ
mice
two
subcutan
inject
two
week
apart
splenic
mononuclear
cell
collect
two
week
second
immun
analyz
cfse
fluoresc
prolifer
assay
hour
antigen
restimul
vitro
gate
strategi
quantifi
prolifer
antigenspecif
cell
illustr
figur
minimum
maximum
median
abund
cell
plot
figur
b
mean
prolif
respons
higher
mice
immun
solubl
ovalbumin
signific
extent
comparison
mice
hand
adjuvant
clr
agonist
result
increas
prolifer
cell
respons
restimul
comparison
cell
mice
immun
ovalbumin
cell
mice
immun
ovalbumin
tdb
contain
addit
cell
similarli
cell
mice
immun
ovalbumin
curdlan
contain
cell
cell
cell
mice
immun
ovalbumin
furfurman
produc
addit
cell
addit
cell
comparison
cell
prolif
respons
composit
contain
clr
agonist
show
signific
differ
observ
data
highlight
potenti
mincl
agonist
adjuv
enhanc
cell
respons
evalu
humor
adapt
immun
respons
induc
composit
contain
antigen
individu
clr
agonist
blood
collect
day
last
inject
mice
immun
assay
total
igg
igg
isotyp
mice
use
control
total
ovalbuminspecif
igg
significantli
abund
mice
inject
ovalbuminclr
agonist
mixtur
mice
immun
solubl
ovalbumin
figur
humor
respons
strongest
significantli
higher
mice
immun
ovalbumin
tdb
geometr
mean
reciproc
igg
titer
comparison
mice
immun
ovalbumin
curdlan
ovalbumin
furfurman
moreov
adjuvant
tdb
induc
highest
level
ovalbuminspecif
geometr
mean
reciproc
titer
although
significantli
elev
figur
b
titer
compar
mice
immun
ovalbumin
tdb
furfurman
titer
higher
latter
former
convers
antibodi
abund
ovacurdlan
group
ovafurfurman
group
collect
result
indic
adjuvant
tdb
curdlan
furfurman
induc
strong
humor
respons
although
result
igg
profil
vari
sinc
strong
mucos
immun
respons
initi
site
infect
essenti
defens
pathogen
investig
whether
mincl
agonist
induc
effect
mucos
immun
end
bronchoalveolar
intestin
lavag
fluid
collect
day
last
immun
mice
immun
describ
assay
antigenspecif
iga
elisa
figur
adjuvant
curdlan
furfurman
significantli
induc
intestin
iga
geometr
mean
iga
titer
comparison
ovalbumin
alon
geometr
mean
iga
titer
contrast
adjuvant
tdb
increas
intestin
iga
slightli
geometr
mean
iga
titer
worth
note
adjuvant
lower
dose
curdlan
furfurman
elicit
signific
product
iga
well
data
shown
adjuvant
higher
concentr
tdb
data
shown
interestingli
parenter
administr
ovalbumin
adjuv
clr
agonist
significantli
induc
bronchoalveolar
iga
taken
togeth
data
suggest
adjuvant
agonist
mincl
agonist
robustli
induc
iga
product
intestin
mucosa
follow
parenter
immun
known
number
vaccin
formul
characterist
chemic
natur
carrier
size
shape
surfac
charg
particl
may
greatli
affect
immunogen
vaccin
exampl
chang
carrier
natur
may
alter
biodistribut
antigen
well
acquisit
process
antigenpres
cell
thu
may
result
chang
adapt
immun
respons
test
whether
intestin
iga
respons
agonist
depend
formul
test
squalen
emuls
contain
ovalbumin
alon
tdb
curdlan
furfurman
prepar
formul
similar
physicochem
characterist
assess
averag
particl
size
zpotenti
tabl
obtain
data
negat
formul
discrep
could
effect
immunogen
except
clr
agonist
content
serum
igg
intestin
iga
measur
two
week
second
inject
mice
immun
primeboost
immun
describ
squalenebas
formul
induc
igg
respons
higher
antigen
mixtur
without
carrier
squalenebas
formul
tdb
curdlan
furfurman
result
significantli
higher
total
igg
resp
ovalbumin
alon
figur
moreov
maxim
mice
immun
ovalbumin
tdb
although
compar
among
group
figur
b
evalu
iga
titer
intestin
lavag
show
mice
vaccin
ovalbumin
curdlan
geometr
mean
iga
titer
furfurman
geometr
mean
iga
titer
present
significantli
increas
iga
rel
mice
vaccin
ovalbumin
geometr
mean
iga
titer
figur
c
howev
adjuvant
tdb
geometr
mean
iga
titer
induc
mucos
iga
thu
stimul
subcutan
vaccin
appear
elicit
mucos
iga
respons
independ
carrier
present
vaccin
formul
collect
gastrointestin
urogenit
respiratori
tract
present
averag
mucos
surfac
area
human
bodi
serv
major
entri
port
numer
viral
bacteri
fungal
pathogen
thu
vaccin
ideal
enabl
induc
mucos
immun
provid
host
defens
point
entri
infecti
agent
least
limit
invas
protect
central
immun
develop
henc
elucid
molecular
cellular
mechan
drive
local
mucos
immun
essenti
develop
effect
parenter
vaccin
recent
develop
suggest
effect
vaccin
requir
suitabl
antigen
appropri
deliveri
system
promot
lymphat
traffick
antigen
uptak
local
antigenpres
cell
also
immunostimulatori
molecul
enhanc
specif
immun
respons
drive
polar
accordingli
discoveri
pattern
recognit
receptor
strongli
regul
innat
adapt
immun
provid
new
opportun
creat
novel
effect
adjuv
base
agonist
howev
abil
induc
local
mucos
immun
reaction
deliv
parenter
character
small
number
adjuv
although
mani
develop
date
ctype
lectin
type
ii
transmembran
pattern
recognit
clr
coupl
syk
detect
pathogenassoci
molecular
pattern
investig
impact
stimul
clr
mincl
innat
well
adapt
immun
includ
local
mucos
system
reaction
sykcoupl
clr
share
signal
pathway
activ
common
set
sever
transcript
factor
includ
nfat
also
major
regul
immun
use
report
cell
deriv
rawblu
cell
natur
express
mincl
demonstr
first
time
stimul
receptor
agonist
like
curdlan
furfurman
tdb
activ
differ
transcript
factor
particular
tdb
furfurman
predominantli
activ
total
luciferas
report
activ
curdlan
predominantli
activ
nfat
although
molecular
mechan
underli
phenomenon
remain
elucid
kinet
receptoragonist
interact
especi
vitro
assay
condit
probabl
critic
differ
downstream
intracellular
signal
exampl
mincl
lack
signal
transduct
motif
requir
transduc
activ
signal
wherea
direct
syk
activ
induc
canon
noncanon
pathway
clr
agonist
also
activ
dendrit
cell
anoth
key
event
adapt
immun
assess
express
costimulatori
molecul
activ
pronounc
respons
tdb
minim
respons
furfurman
also
found
clr
agonist
induc
product
cytokin
dendrit
mononuclear
cell
accord
accept
model
activ
dendrit
cell
commun
inform
invad
pathogen
via
cytokin
profil
drive
th
cell
differenti
howev
tdb
induc
maxim
level
cytokin
hand
stimul
curdlan
furfurman
correspondingli
predominantli
induc
cytokin
includ
especi
moreov
found
respons
agonist
bone
marrowderiv
dendrit
cell
produc
cytokin
essenti
iga
cell
switch
b
cell
due
promis
result
evalu
central
local
mucos
immun
respons
ovalbumin
adjuv
tdb
curdlan
furfurman
cell
prolifer
vitro
restimul
compar
among
group
central
igg
local
iga
respons
markedli
differ
tdb
induc
strongest
central
immun
respons
indic
total
igg
sera
hand
curdlan
furfurman
induc
stronger
local
mucos
immun
reaction
tdb
measur
intestin
iga
result
consist
abil
furfurman
curdlan
induc
primarili
central
mucos
immun
howev
curdlan
furfurman
stimul
iga
secret
lung
mucosa
follow
subcutan
immun
line
previou
studi
tdb
mix
adjuv
significantli
increas
lung
iga
subcutaneousintranas
primeboost
immun
subcutaneoussubcutan
immun
data
indic
immun
strategi
also
impact
mucos
immun
reaction
simplifi
illustr
summar
differ
clr
agonist
th
polar
mucos
iga
product
present
figur
final
show
squalenebas
formul
affect
iga
respons
clr
agonist
suggest
observ
effect
parenter
immun
depend
biodistribut
depot
effect
mainli
due
abil
agonist
especi
curdlan
furfurman
induc
mucos
immun
reaction
along
propos
inclus
agonist
vaccin
composit
may
significantli
enhanc
format
mucos
iga
immun
respons
independ
carrier
natur
vaccin
composit
taken
togeth
result
impli
new
adjuv
base
agonist
may
significantli
enhanc
mucos
immun
reaction
newli
design
alreadi
prepar
parenter
vaccin
thu
may
simultan
induc
central
local
immun
confer
robust
longliv
protect
mucos
pathogen
support
assumpt
studi
requir
elucid
protect
effici
newli
prepar
parent
vaccin
contain
agonist
adjuv
differ
experiment
mucos
infect
exampl
salmonella
candida
infect
also
import
establish
potenti
safeti
pitfal
newli
identifi
clrbase
adjuv
one
could
expect
abil
prr
agonist
induc
system
cytokin
unwant
side
effect
parent
administr
summari
demonstr
first
time
despit
engag
common
set
signal
pathway
stimul
sykcoupl
clr
mincl
use
agonist
tdb
curdlan
furfurman
result
differenti
activ
transcript
factor
nfat
matur
dendrit
cell
cytokin
secret
bone
marrowderiv
dendrit
cell
splenic
mononuclear
cell
system
igg
product
local
mucos
adapt
immun
also
demonstr
first
time
stimul
mincl
along
ovalbumin
antigen
induc
robust
formulationindepend
secret
iga
intestin
mucosa
even
deliv
parenter
overal
studi
highlight
agonist
adjuv
may
induc
local
immun
reaction
intestin
mucosa
thu
significantli
improv
efficaci
parenter
vaccin
